Alam Sutera Realty Tbk (ASRI)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 93.00 |
|---|---|
| 52-week range | 91.00 – 201.32 |
| Return, 1 month / 3 months | −25.0% / −25.0% |
| Return, 1 year / 3 years | −44.6% / −47.1% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 47.3% |
| Worst drawdown (1 year) | -50.4% |
| Average daily value traded | 1,504.12M IDR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alam Sutera Realty is an Indonesian property developer based in Tangerang, near Jakarta. The company develops and manages large-scale townships, building residential clusters, houses and apartments alongside commercial space such as shopping centres, office buildings and hotels. Its customers are mainly homebuyers and businesses in the greater Jakarta area, and it also develops land and sells plots within its estates. The company's activities span property development, project management and the operation of retail and hospitality assets in its townships.
On this site Alam Sutera Realty Tbk appears as a stock on the Jakarta Exchange (Indonesia), code ASRI, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alam Sutera Realty Tbk (ASRI) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 93.00 on 19 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 584 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 44.6% and over the last three months it fell 25.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.9% | ||
| From 52-week high | -50.4% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.0% | ||
| 6-month return | -28.6% | ||
| 12-month return, skipping the last month | -26.1% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.4% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,504.12M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 14 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −19.8% |
|---|---|
| 1 month | −25.0% |
| 3 months | −25.0% |
| 6 months | −28.6% |
| 1 year | −44.6% |
| 3 years | −47.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 121.46 / 130.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | IDR 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.